Fungi: The neglected allergenic sources

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 2, 2014, Pages 176-185

  Crameri, R ^a   Garbani, M ^a   Rhyner, C ^a   Huitema, C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

allergy; fungi; immunoglobulin E; moulds; recombinant allergens

Indexed keywords

ALLERGEN; CORTICOSTEROID DERIVATIVE; ITRACONAZOLE; PLACEBO;

ALLERGIC ASTHMA; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY; ANTIMICROBIAL THERAPY; ATOPIC DERMATITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; FUNGUS; HUMAN; MYCOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINOSINUSITIS; UNSPECIFIED SIDE EFFECT;

ALLERGY; FUNGI; IMMUNOGLOBULIN E; MOULDS; RECOMBINANT ALLERGENS;

ANTIGENS, FUNGAL; FUNGI; HUMANS; HYPERSENSITIVITY; MOLECULAR SEQUENCE DATA;

EID: 84893710698     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12325     Document Type: Review

References (152)

1. Greiner AN, Hellings PW, Rotiroti G, Scadding GK,. Allergic rhinitis. Lancet 2011; 378: 2112-2122.
2. Sullivan SD, Turk F,. An evaluation of the cost-effectivness of omalizumab for the treatment of severe allergic asthma. Allergy 2008; 63: 670-684. (Pubitemid 351591863)
3. Bieber T, Cork M, Reitamo S,. Atopic dermatitis: a candidate for disease-modifying strategy. Allergy 2012; 67: 969-975.
4. Berin MC, Sicherer S,. Food allergy: mechanisms and therapeutics. Curr Opin Immunol 2011; 23: 794-800.
5. Müller UR,. Insect venoms. Chem Immunol Allergy 2010; 95: 141-156.
6. Galli SJ, Tsai M, Piliponsky AM,. The development of allergic inflammation. Nature 2008; 254: 445-454.
7. Zeller S, Glaser AG, Vilhelmsson M, Rhyner C, Crameri R,. Cross-reactivity among fungal allergens: a clinically relevant phenomenon? Mycoses 2009; 52: 99-106.
8. Crameri R,. Immunoglobulin E-binding autoantigens: biochemical characterization and clinical relevance. Clin Exp Allergy 2012; 42: 343-351.
9. Hamilton RG, Donald MacGlashan WW Jr, Saini SS,. IgE antibody-specific activity in human allergic disease. Immunol Res 2010; 47: 273-284.
10. Hamilton RG, Adkinson FN Jr,. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol 2004; 114: 213-215.
11. Peavy RD, Metcalfe DD,. Understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol 2008; 83: 305-310.
12. Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011; 66: 596-604.
13. Boyce JA, Bochner B, Finkelman FD, Rothenberg ME,. Advances in mechanisms of asthma, allergy, and immunology in 2011. J Allergy Clin Immunol 2012; 129: 335-341.
14. Crameri R,. Allergy diagnosis, allergen repertoires, and their implication in allergen-specific immunotherapy. Immunol Allergy Clin North Am 2006; 26: 179-189.
15. Stadler MB, Stadler BM,. Allergenicity prediction by protein sequence. FASEB J 2003; 17: 1141-1143.
16. Li KB, Issac P, Krishnan A,. Predicting allergenic proteins using wavelet transform. Bioinformatics 2004; 20: 2572-2578. (Pubitemid 39530143)
17. Chapman MD, Pomés A, Breiteneder H, Ferreira F,. Nomenclature and structural biology of allergens. J Allergy Clin Immunol 2007; 119: 414-420.
18. Custovic A, Simpson A,. The role of inhalant allergens in allergic airways disease. J Invest Allergol Clin Immunol 2012; 22: 393-401.
19. Kennedy JL, Heymann PW, Platts-Mills TAE,. The role of allergy in severe asthma. Clin Exp Allergy 2012; 42: 659-669.
20. Agarwal R, Gupta D,. Severe asthma and fungi: current evidence. Med Mycol 2011; 49 (Suppl 1): S150-S157.
21. Green BJ, Tovey ER, Sercombe JK, Blachere FM, Beezhold DH, Schmechel D,. Airborne fungal fragments and allergenicity. Med Mycol 2006; 44 (Suppl 1): S245-S255.
22. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A,. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 2012; 25: 106-141.
23. Simon-Nobbe B, Denk U, Pöll V, Rid R, Breitenbach M,. The spectrum of fungal allergy. Int Arch Allergy Immunol 2008; 145: 58-86.
24. Prillinger H, Lopandic K, Schweigkofler W, Deak R, Aarts HJ, Bauer R, et al. Phylogeny and systematics of the fungi with special reference to the Ascomycota and Basidiomycota. Chem Immunol 2002; 81: 207-295. (Pubitemid 34625316)
25. Horner WE, Helbling A, Salvaggio EJ, Lehrer SB,. Fungal allergens. Clin Microbiol Rev 1995; 8: 161-179.
26. Bush RK, Portneoy JA, Saxon A, Terr AI, Wood RA,. The medical effects of mold exposure. J Allergy Clin Immunol 2006; 117: 326-333. (Pubitemid 43190147)
27. Crameri R, Weichel M, Flückiger S, Glaser AG, Rhyner C,. Fungal allergies: a yet unsolved problem. Chem Immunol Allergy 2006; 91: 121-133. (Pubitemid 43097201)
28. Schmid-Grendelmeier P, Scheynius A, Crameri R,. The role of sensitization to Malassezia sympodialis in atopic eczema. Chem Immunol Allergy 2006; 91: 98-109. (Pubitemid 43097199)
29. Mari A, Schneider P, Wally V, Breitenbach M, Simon-Nobbe B,. Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy 2003; 33: 1429-1438. (Pubitemid 37289941)
30. Esch RE,. Manufacturing and standardizing fungal allergen products. J Allergy Clin Immunol 2004; 113: 210-215. (Pubitemid 38210538)
31. D'Amato G, Chatzigeorgiou G, Corsico R, Gioulekas D, Jäger L, Jäger S, et al. Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. A European multicenter study promoted by the Subcommittee on Aerobiology and Environmental Aspects of Inhalant Allergens of the European Academy of Allergology and Clinical Immunology. Allergy 1997; 52: 711-716.
32. Vailes L, Sridhara S, Cromwell O, Weber B, Breitenbach M, Chapman M,. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol 2001; 107: 641-646. (Pubitemid 32397751)
33. Coombs RRA, Gell PGH,. Clinical Aspects of Immunology. Oxford: Blackwell Scientific Publications, 1963.
34. Descotes J, Choquet-Kastylevsky G,. Gell and Coomb's classification: is it still valid? Toxicol 2001; 158: 43-49. (Pubitemid 32119495)
35. Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al. Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012; 130: 1049-1062.
36. Holgate ST,. Innate and adaptive immune responses in asthma. Nat Med 2012; 18: 673-683.
37. Casagrande BF, Flückiger S, Linder MT, Johansson C, Scheynius A, Crameri R, et al. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic eczema. J Invest Dermatol 2006; 126: 2414-2421. (Pubitemid 44582263)
38. Foreman A, Boase S, Psaltis A, Wormald PJ,. Role of bacterial and fungal biofilms in chronic rhinosinusitis. Curr Allergy Asthma Rep 2012; 12: 127-135.
39. Hamilos DL,. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol 2011; 128: 93-707.
40. Kurup VP,. Fungal Allergy. In:, Arora N, editor. Handbook of Fungal Biotechnology. New York: Dekker, 2003: 515-525.
41. Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, Fairs A, et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129: 280-291.
42. Akinbami LJ,. Asthma prevalence, health care use, and mortality: United States 2005-2009. Natl Health Stat Report 2011; 32: 1-16.
43. Patterson K, Strek ME,. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 2010; 7: 237-244.
44. Slavin RK, Stanczyk DJ, Lonigro AJ, Brown GS,. Allergic bronchopulmonary aspergillosis: a North American rarity. Am J Med 1969; 47: 306-313.
45. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (Suppl 3): S225-S264. (Pubitemid 37260463)
46. Basica JE, Graves TS, Baz MN,. Allergic bronchopulmonary aspergillosis in corticoid dependent asthmatics. J Allergy Clin Immunol 1981; 68: 98-102. (Pubitemid 11047185)
47. Laufer P, Fink JN, Bruns WT, Unger GF, Kalbfleisch JH, Greenberger PA, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984; 73: 44-48. (Pubitemid 14185120)
48. Denning DW, Pleuvry A, Cole DC,. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 2013; 51: 361-370.
49. Greenberger PA, Miller TP, Roberts M, Smith LL,. Allergic bronchopulmonary aspergillosis in patients with and without bronchiectasis. Ann Allergy 1993; 70: 333-338. (Pubitemid 23110029)
50. Hafen GM, Hartl D, Regamey N, Casaulta C, Latzin P,. Allergic bronchopulmonary aspergillosis: the hunt for a diagnostic serological marker in cystic fibrosis patients. Expert Rev Mol Diagn 2009; 9: 157-164.
51. Greenberger PA, Patterson R,. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 1988; 81: 645-650.
52. Ogawa H, Fujimura M, Takeuchi Y, Makimura K, Satoh K,. The definitive diagnostic process and successful treatment for ABPM caused by Schizophyllum commune: a report of two cases. Allergol Int 2012; 61: 163-169.
53. Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127: 355-3601.
54. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM,. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-625.
55. Agarwal R,. Severe asthma with fungal sensitization. Curr Allergy Asthma Rep 2011; 11: 403-413.
56. Simon D, Kernland Lang K,. Atopic dermatitis: from new pathogenic insights toward a barrier-restoring and anti-inflammatory therapy. Curr Opin Pediatr 2011; 23: 647-652.
57. Novak N, Simon D,. Atopic dermatitis-from new pathophysiologic insights to individualized therapy. Allergy 2011; 66: 830-839.
58. Wolf R, Wolf D,. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol 2012; 30: 329-334.
59. Vilhelmsson M, Glaser AG, Martinez DB, Schmidt M, Johansson C, Rhyner C, et al. Mutational analysis of amino acid residues involved in IgE-binding to the Malassezia sympodialis allergen Mala s 11. Mol Immunol 2008; 46: 294-303.
60. Schmid-Grendelmeier P, Flückiger S, Disch R, Trautmann A, Wüthrich B, Blaser K, et al. IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005; 115: 1068-1075. (Pubitemid 40616225)
61. Vilhelmsson M, Johansson C, Jacobsson-Ekman G, Crameri R, Zargari A, Scheynius A,. The Malassezia sympodialis allergen Mala s 11 induces human dendritic cell maturation, in contrast to its human homologue manganese superoxide dismutase. Int Arch Allergy Immunol 2007; 143: 155-162. (Pubitemid 46742352)
62. Balaji H, Heratizadeh A, Wichmann K, Niebuhr M, Crameri R, Scheynius A, et al. Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis. J Allergy Clin Immunol 2011; 128: 92-99.
63. Hradetzky S, Roesner LM, Heratizadeh A, Crameri R, Scheynius A, Werfel T,. Cytokine responses induced by the human autoallergen thioredoxin. Exp Dermatol 2013; 20: E3.
64. Zeller S, Rhyner C, Meyer N, Schmid-Grendelmeier P, Akdis CA, Crameri R,. Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. J Allergy Clin Immunol 2009; 124: 278-285.
65. Kortekangas-Savolainen O, Lammintausta K, Kalimo K,. Skin prick test reactions to brewer's yeast (Saccharomyces cerevisiae) in adult atopic dermatitis patients. Allergy 1993; 48: 147-150. (Pubitemid 23125918)
66. Kodzius R, Rhyner C, Konthur Z, Buczek D, Lehrach H, Walter G, et al. Rapid identification of allergen-encoding cDNA clones by phage display and high-density arrays. Comb Chem High Throughput Screen 2003; 6: 147-154. (Pubitemid 36389519)
67. Crameri R, Kodzius R, Konthur Z, Lehrach H, Blaser K, Walter G,. Tapping allergen repertoires by advanced cloning technologies. Int Arch Allergy Immunol 2001; 124: 43-47. (Pubitemid 32304757)
68. Kao R, Martínez-Ruiz A, Martínez del Pozo A, Crameri R, Davies J,. Mitogillin and related fungal ribotoxins. Methods Enzymol 2001; 341: 324-335. (Pubitemid 32928535)
69. Bowyer P, Fraczek M, Denning DW,. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genomics 2006; 7: 251.
70. Aalberse RC, Crameri R,. IgE-binding epitopes: a reappraisal. Allergy 2011; 66: 1261-1274.
71. Soeria-Atmadja D, Onnel A, Borga A,. IgE sensitization to fungi mirror fungal phylogenetic systematic. J Allergy Clin Immunol 2010; 125: 1379-1386.
72. Glaser AG, Menz G, Kirsch AI, Zeller S, Crameri R, Rhyner C,. Auto- and cross-reactivity to thioredoxin allergens in allergic bronchopulmonary aspergillosis. Allergy 2008; 63: 1617-1623.
73. Hemmann S, Blaser K, Crameri R,. Allergens of Aspergillus fumigatus and Candida boidiini share IgE-binding epitopes. Am J Respir Crit Care Med 1997; 156: 1956-1962. (Pubitemid 28011807)
74. Flückiger S, Mittl PR, Scapozza L, Fijten H, Folkers G, Grütter MG, et al. Comparison of the crystal structures of the human manganese superoxide dismutase and the homologous Aspergillus fumigatus allergen at 2- Å resolution. J Immunol 2002; 168: 1267-1272. (Pubitemid 34094494)
75. Glaser AG, Limacher A, Flückiger S, Scheynius A, Scapozza L, Crameri R,. Analysis of the cross-reactivity and of the 1.5 Å structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem J 2006; 396: 41-49. (Pubitemid 43764495)
76. Limacher A, Glaser AG, Meier C, Schmid-Grendelmeier P, Zeller S, Scapozza L, et al. Cross-reactivity and 1.4-Å crystal structure of Malassezia sympodialis thioredoxin (Mala s 13), a member of a new pan-allergen family. J Immunol 2007; 178: 389-396. (Pubitemid 46033622)
77. Limacher A, Kloer DP, Flückiger S, Folkers G, Crameri R, Scapozza L,. The crystal structure of Aspergillus fumigatus cyclophilin reveals 3D domain swapping of a central element. Structure 2006; 14: 185-195. (Pubitemid 43202008)
78. Vilhelmsson M, Zargari A, Crameri R, Rasool O, Achour A, Scheynius A, et al. Crystal structure of the major Malassezia sympodialis allergen Mala s 1 reveals a beta-propeller fold: a novel fold among allergens. J Mol Biol 2007; 369: 1079-1086. (Pubitemid 46754069)
79. Yang X, Moffat K,. Insights into specificity of cleavage and mechanisms of cell entry from the crystal structure of the highly specific Aspergillus ribotoxin, restrictocin. Structure 1996; 4: 837-852. (Pubitemid 26312367)
80. Nüss D, Goettig P, Magler I, Denk U, Breitenbach M, Schneider PB, et al. Crystal structure of NADP-dependent mannitol dehydrogenase from Cladosporium herbarum: implication for oligomerisation and catalysis. Biochemie 2010; 92: 985-993.
81. Chruszcz M, Chapman MD, Osinski T, Solberg R, Demas M, Porebski PJ, et al. Alternaria alternata allergen Alt a 1: a unique β-barrel protein dimer found exclusively in fungi. J Allergy Clin Immunol 2012; 130: 241-247.
82. Falsone SF, Weichel M, Crameri R, Breitenbach M, Kungl AJ,. Unfolding and double-stranded DNA binding of the cold shock protein homologue Cla h 8 from Cladosporium herbarum. J Biol Chem 2001; 277: 16512-16516. (Pubitemid 34967666)
83. Weichel M, Schmid-Grendelmeier P, Flückiger S, Breitenbach M, Blaser K, Crameri R,. Nuclear transport factor 2 represents a novel cross-reactive fungal allergen. Allergy 2003; 58: 198-206. (Pubitemid 36609357)
84. Rid R, Onder K, Hawranek T, Laimer M, Bauer JW, Holler C, et al. Isolation and immunological characterization of a novel Cladosporium herbarum allergen structurally homologous to the alpha/beta hydrolase fold superfamily. Mol Immunol 2010; 47: 1366-1377.
85. Flückiger S, Scapozza L, Mayer C, Blaser K, Folkers G, Crameri R,. Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases. Int Arch Allergy Immunol 2002; 128: 292-303.
86. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K,. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998; 10: 1211-1216. (Pubitemid 28362696)
87. Hemmann S, Nikolaizik WH, Schöni MH, Blaser K, Crameri R,. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998; 28: 1155-1160. (Pubitemid 28156405)
88. Kurup VP, Knutsen AP, Moss RB, Bansal NK,. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Mol Allergy 2006; 21: 4-11.
89. Knutsen AP, Slavin RG,. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011; 2011: 843763.
90. Slavin RG, Knutsen AP,. Purified Aspergillus proteins: going where no one has gone before. J Lab Clin Med 1993; 121: 380-381. (Pubitemid 23105698)
91. Crameri R,. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998; 115: 99-114. (Pubitemid 28048339)
92. Burbach GJ, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, et al. GA(2)Len skin test study II: clinical relevance of inhalant allergen sensitization in Europe. Allergy 2009; 64: 1507-1515.
93. Crameri R,. The crux with a reliable in vitro and in vivo diagnosis of allergy. Allergy 2013; 68: 693-694.
94. American Academy of Allergy. Asthma and Immunology (AAAAI). The use of standardized allergen extracts. J Allergy Clin Immunol 1997; 99: 583-586.
95. Slater JE, Menzies SL, Bridgewater J, Mosquera A, Zinderman CE, Ou AC, et al. The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts. J Allergy Clin Immunol 2012; 129: 1014-1019.
96. Wallenbeck I, Aukrust L, Einarsson R,. Antigenic variability of different strains of Aspergillus fumigatus. Int Arch Allergy Appl Immunol 1984; 73: 166-172. (Pubitemid 14180449)
97. Reed C,. Variability of antigenicity of Aspergillus fumigatus. J Allergy Clin Immunol 1978; 61: 227-229. (Pubitemid 8329500)
98. Kauffman HF, van der Heide S, van der Laan S, Hovenga H, Beaumont F, de Vries K,. Standardization of allergenic extracts of Aspergillus fumigatus: liberation of IgE-binding components during cultivation. Int Arch Allergy Appl Immunol 1985; 76: 168-173. (Pubitemid 15159801)
99. Esch RE,. Role of proteases on the stability of allergenic extracts. In:, Klein R, editor. Regulatory Control and Standardization of Allergenic Extracts. Stuttgart: Fischer, 1990: 171-177.
100. Kauffman HF, van der Heide S, de Vries K,. Antigenic composition of Aspergillus fumigatus in relation to the conditions of growth. In:, Poucard T, Dreborg S, editors. Mould Allergy Workshop. Uppsala: Pharmacia, 1994: 43-44.
101. Kurup VP, Shen HD, Vijay H,. Immunobiology of fungal allergens. Int Arch Allergy Immunol 2002; 129: 181-188. (Pubitemid 35365357)
102. Nikolaizic WH, Crameri R, Blaser K, Schöni MH,. Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis. Int Arch Allergy Immunol 1996; 111: 403-408. (Pubitemid 26390343)
103. ® system in Korean allergy patients. Clin Chim Acta 2012; 413: 914-919.
104. Altmann F,. The role of glycoproteins in allergy. Int Arch Allergy Immunol 2007; 142: 99-115.
105. Schmid-Grendelmeier P, Crameri R,. Recombinant allergens for skin testing. Int Arch Allergy Immunol 2001; 125: 96-111. (Pubitemid 32642047)
106. Larenas-Linnemann D, Cox LS,. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008; 100: 137-145. (Pubitemid 351238549)
107. Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002; 16: 414-416.
108. Harwanegg Ch, Hiller R,. Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development. Eur Ann Allergy Clin Immunol 2006; 38: 232-236. (Pubitemid 44606238)
109. Lucas LM,. Microarrays: molecular Allergology and nanotechnology for personalised medicine (I). Allergol Immunopathol (Madr) 2010; 38: 153-161.
110. Bonini M, Marcomini L, Gramiccioni C, Tranquilli C, Melioli G, Canonica GW, et al. Microarray evaluation of specific IgE to allergen components in elite athletes. Allergy 2012; 67: 1557-1564.
111. Müller U, Fricker M, Wymann D, Blaser K, Crameri R,. Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2. Clin Exp Allergy 1997; 27: 915-920. (Pubitemid 27359858)
112. Thomas WR,. The advent of recombinant allergens and allergen cloning. J Allergy Clin Immunol 2011; 127: 855-859.
113. Thia LP, Balfour Lynn IM,. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Paediatr Respir Rev 2009; 10: 37-42.
114. Caubet JC, Kondo Y, Urisu A, Nowak-Wegrzyn A,. Molecular Diagnosis of egg allergy. Curr Opin Allergy Clin Immunol 2011; 11: 210-215.
115. De Knop KJ, Bridts CH, Verweij MM, Hagendorens MM, De Clerck LS, Stevens WJ, et al. Component-resolved allergy diagnosis by microarrays: potential, pitfalls and prospects. Adv Clin Chem 2010; 50: 87-101.
116. Treudler R, Simon JC,. Overview of component resolved diagnostics. Curr Allergy Asthma Rep 2013; 13: 110-117.
117. Burr ML, Matthews IP, Arthur RA, Watson HL, Gregory CJ, Dunstan FD, et al. Effects on patients with asthma of eradicating visible indoor mould: a randomized controlled trial. Thorax 2007; 62: 767-772.
118. Kopp VP,. Role of immunomodulators in allergen-specific immunotherapy. Allergy 2011; 66: 792-797.
119. Ring J, Gutermuth J,. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 2011; 66: 713-724.
120. Helbling A, Reimers A,. Immunotherapy in fungal allergy. Curr Allergy Asthma Rep 2003; 3: 447-453. (Pubitemid 38899112)
121. Malling HJ,. Immunotherapy for mold allergy. Clin Rev Allergy 1992; 10: 237-251.
122. Louis R, Schleich F, Barnes PJ,. Corticosteroids: still at the frontline in asthma treatment? Clin Chest Med 2012; 33: 531-541.
123. Rosenberg M, Patterson R, Roberts M, Wang J,. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978; 64: 599-606. (Pubitemid 8322908)
124. DuBuske LM,. Twenty-four-hour duration of effect of intranasal corticosteroids for seasonal allergic rhinitis symptoms: clinical evidence and relevance. Am J Rhinol Allergy 2012; 26: 287-292.
125. Seaton A, Seaton RA, Withtman AJ,. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow up. QJM 1994; 87: 529-537. (Pubitemid 24289823)
126. Hilton AM, Chatterjee SS,. Bronchopulmonary aspergillosis-treatment with beclomethasone dipropionate. Postgrad Med J 1975; 51 (Suppl 4): 98-103.
127. Bodor N, Buchwald P,. Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroids. Curr Pharmacol Des 2006; 12: 3241-3260. (Pubitemid 44375467)
128. Wark P, Gibson PG, Wilson A,. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2004; 3: CD001108.
129. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. New Engl J Med 2000; 11: 756-762. (Pubitemid 30151919)
130. Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, et al. Anti-inflammatory effects of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952-957. (Pubitemid 36570853)
131. Crameri R, Blaser K,. Allergy and immunity to fungal infections and colonization. Eur Respir J 2002; 19: 151-157. (Pubitemid 34105583)
132. Tuite NL, Lacey K,. Overview of invasive fungal infections. Methods Mol Biol 2013; 968: 1-23.
133. Livermore J, Hope W,. Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections. Expert Opin Drug Metab Toxicol 2012; 8: 759-765.
134. Hawranek T,. Cutaneous Mycology. Chem Immunol 2002; 81: 129-166. (Pubitemid 34625314)
135. Fishwick D,. New occupational and environmental causes of asthma and extrinsic allergic alveolitis. Clin Chest Med 2012; 33: 605-616.
136. Selman M, Lacasse Y, Pardo A, Cormier Y,. Hypersensitivity pneumonitis caused by fungi. Proc Am Thorac Soc 2010; 7: 229-236.
137. Kurup VP, Kumar A,. Immunodiagnosis of aspergillosis. Clin Microbiol Rev 1991; 4: 439-456. (Pubitemid 21920408)
138. Radauer C, Nandy A, Ferreira F, Goodman RE, Larsen JN, Lidholm J, et al. Update of the WHO/IUIS Allergen Nomenclature Database based on analysis of allergen sequences. Allergy 2014, doi: 10.1111/all.12348.
139. Nolles G, Hoekstra MO, Schouten JP, Gerritsen J, Kauffman HF,. Prevalence of immunoglobulin E for fungi in atopic children. Clin Exp Allergy 2011; 31: 1564-1570.
140. Gioulekas D, Damialis A, Papakosta D, Spieksma F, Giouleka P, Patakas D,. Allergenic fungi spore records (15 years) and sensitization in patients with respiratory allergy in Thessaloniki-Greece. J Investig Allergol Clin Immunol 2004; 14: 225-231. (Pubitemid 39390279)
141. Ezeamuzie CI, Al-Ali S, Khan M, Hijazi Z, Dowaisan A, Thomson MS, et al. IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment. Int Arch Allergy Immunol 2000; 121: 300-307. (Pubitemid 30229642)
142. Green BJ, Blachere FM, Beezhold DH, Weissman DN, Hogan MB, Wilson NW, et al. IgE reactivity to Paecilomyces variotii antigens in fungal sensitized patients. J Allergy Clin Immunol 2007; 119: S187.
143. Simons FE, Sheikh A,. Anaphylaxis: the acute episode and beyond. BMJ 2013; 346: f602.
144. Kalish RS, Askenase PW,. Molecular mechanisms of CD8 + T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J Allergy Clin Immunol 1999; 103: 192-199. (Pubitemid 29095820)
145. Karsten CM, Köhl J,. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases. Immunobiol 2012; 217: 1067-1079.
146. Spiewak R,. Contact dermatitis in atopic individuals. Curr Opin Allergy Clin Immunol 2012; 12: 491-497.
147. Gideon HP, Flynn JL,. Latent tuberculosis: what the host "sees"? Immunol Res 2011; 50: 202-212.
148. Moser M, Crameri R, Menz G, Schneider T, Dudler T, Virchow C, et al. Cloning and expression of recombinant Aspergillus fumigatus allergenI/a (rAsp f I/a) with IgE binding and type I skin test activity. J Immunol 1992; 149: 454-460.
149. Flückiger S, Fijten H, Whitley P, Blaser K, Crameri R,. Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol 2002; 32: 10-17. (Pubitemid 34092817)
150. Glaser AG, Kirsch AI, Zeller S, Menz G, Rhyner C, Crameri R,. Molecular and immunological characterization of Asp f 34, a novel major cell wall allergen of Aspergilus fumigatus. Allergy 2009; 64: 1144-1151.
151. Schneider PB, Denk U, Breitenbach M, Richter K, Schmid-Grendelmeier P, Nobbe S, et al. Alternaria alternata NADP-dependent mannitol dehydrogenase is an important fungal allergen. Clin Exp Allergy 2006; 36: 1513-1524. (Pubitemid 44902928)
152. Shen HD, Tam MF, Chou H, Han SH,. The importance of serine proteinases as aeroallergens associated with asthma. Int Arch Allergy Immunol 1999; 119: 259-264. (Pubitemid 29401694)